Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.
about
Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicityA mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent modelsProteomics and metabolomics in renal transplantation-quo vadis?Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical ResearchEffects of valproic acid and dexamethasone administration on early bio-markers and gene expression profile in acute kidney ischemia-reperfusion injury in the ratCall for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical usePredictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat modelTissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in ratsFibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injuryNephron organoids derived from human pluripotent stem cells model kidney development and injurysiRNA-mediated knock-down of NOX3: therapy for hearing loss?A biophysical indicator of vaso-occlusive risk in sickle cell disease.Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease.Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development.SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trialBiological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.Kidney injury molecule-1: a translational journey.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Gene expression analysis reveals the cell cycle and kinetochore genes participating in ischemia reperfusion injury and early development in kidney.KAP degradation by calpain is associated with CK2 phosphorylation and provides a novel mechanism for cyclosporine A-induced proximal tubule injuryProtective effects of 2-deoxy-D-glucose on nephrotoxicity induced by cyclosporine A in ratsTIM2 gene deletion results in susceptibility to cisplatin-induced kidney toxicity.Biomarkers for early detection of sickle nephropathyBlood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetesHsp72 is a novel biomarker to predict acute kidney injury in critically ill patients.The use of targeted biomarkers for chronic kidney disease.Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasisToxicologic pathology in the 21st century.Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injuryAnalysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomesRegression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.Drug-induced impairment of renal function.Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptionsIschemic kidney injury and mechanisms of tissue repair.Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial.Kidney injury molecule-1 expression is closely associated with renal allograft damage.Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.
P2860
Q21089700-ECB14423-C6DC-49AD-9A9E-2AB6694C5A6FQ24612184-B5563D41-01C8-4E40-BA88-ECFA9B81F338Q27024418-FC950206-5809-42EB-9739-4F757BB46BACQ27024682-60E4BE1C-D4C3-49A9-85F0-8B744C204F89Q27307274-83B4EA3F-CFB0-427D-BF1D-9204D042D1DDQ28081433-2925FB26-A270-4156-A129-DADC5CD9B06CQ28541349-2488497C-1163-405F-B0EC-97A007B1AECCQ28572929-EFB76CC0-0400-4D45-B003-E142352317BAQ28573774-6DD27F23-3A98-4665-9CDC-8049BCAF9A22Q29037394-A090EFD4-EF66-4167-A936-2209AC7BB936Q30355898-D8E42D7B-28B7-41FC-B0DB-260AF30DCA18Q30539106-CC49AA4D-2CA6-446C-8CE1-90068A742D02Q33415013-8767CD6B-A2D1-45C0-B440-58FDB11DA23EQ33789814-032D890E-9E14-480C-B453-EF753D6DF0DDQ33828918-D5A19F9D-DD85-4494-83D0-EFBD58E0E134Q33887958-CBF198F6-5559-4E84-9A52-46623F660259Q33890104-E1DD07E1-4CD4-45DC-9E21-7BE5FD430202Q33905075-DFEF15CE-3AB3-4C6D-A9E0-A5123824F8DFQ33957747-C083CBAF-B588-4CC8-8907-68E6E9B38C8FQ34039254-34D9C8EF-F6D8-4924-B4C2-D31D8EE54DEDQ34043476-688EC6F9-AFFF-4BD3-9624-F7F3A11564F3Q34043503-8FE6CD30-756E-4450-B347-D6DFE1EE239CQ34121284-BC67D01B-CE57-43BA-A84E-05015E61DCE2Q34200665-9EB0A43E-3DD8-48F9-B5C3-6A062B87F86FQ34204444-DA5910D0-4245-4DB8-887E-FC54F41274FEQ34260018-62D778BE-041C-4860-AE95-97DA2280E05DQ34338185-2A56DD48-9E18-45D0-AE76-13FFD378E802Q34346928-9479F096-DABE-4865-A316-B7A044F25815Q34390535-5EDA164E-DD9F-4903-B977-FEE69CF6D8A2Q34473377-A2546FAD-C20E-4157-9441-2A3F1022C6EEQ34525152-AE52D2EC-15FA-4DE3-8ABE-A3A423CD80F0Q34525437-BFBFAE27-13E6-4011-9DE1-FB2D2645E92AQ34552269-90E4BEFB-2CB9-4167-9184-062F92067DCDQ34731462-ECC555A1-B664-43EA-B8F9-9E24E461E625Q34814081-5AE30A5D-28C3-442D-AFD2-3BF915B2A539Q34928175-BEC2C540-8E63-4C53-9072-13AB8AE45B37Q34979691-CB81371E-FDD6-4245-8B4F-A5702578E3C2Q35089582-BD5FC892-1F91-4F00-B7C2-852C250CC56BQ35099941-AFC06C1A-5B22-4214-ABFA-D0144F68EC91Q35106649-65E96A89-2635-49BC-9CE1-10300488BDC3
P2860
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@ast
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@en
type
label
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@ast
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@en
prefLabel
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@ast
Kidney injury molecule-1 outpe ...... omarker qualification studies.
@en
P2093
P2860
P50
P356
P1433
P1476
Kidney injury molecule-1 outpe ...... iomarker qualification studies
@en
P2093
André Cordier
Daniel J Holder
Douglas Thudium
Elias Perentes
Estelle Marrer
Fitz B Collings
Frank D Sistare
Frank Dieterle
Gérard Maurer
Jacky Vonderscher
P2860
P2888
P304
P356
10.1038/NBT.1623
P577
2010-05-01T00:00:00Z